Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BLADDER AND BOWEL DYSFUNCTION”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04464967
What this trial is testing

Safety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR Cancers

Who this might be right for
Advanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more
NKGen Biotech, Inc.
Not applicableLooking for participantsNCT04075305
What this trial is testing

The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Who this might be right for
OncologyBreast CancerProstate Cancer+35 more
UMC Utrecht 8,000
Not applicableStudy completedNCT00253383
What this trial is testing

Early Intervention vs. Standard Palliative Care in Improving End-of-Life Care in Advanced Cancer Patients

Who this might be right for
Cancer
Dartmouth-Hitchcock Medical Center 329
Not applicableStudy completedNCT05461430
What this trial is testing

Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)

Who this might be right for
Pleural Effusion, MalignantAscites, MalignantCarcinoma+29 more
Travera Inc 72
Early research (Phase 1)Study completedNCT03454451
What this trial is testing

CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers

Who this might be right for
Non-Small Cell Lung CancerRenal Cell CancerColorectal Cancer+10 more
Corvus Pharmaceuticals, Inc. 117
Not applicableUnknownNCT04235556
What this trial is testing

Integrated Care Pathway in Oncology (PASSION)

Who this might be right for
Colon CancerGastric CancerPancreatic Cancer+5 more
Assistance Publique - Hôpitaux de Paris 1,800
Not applicableLooking for participantsNCT07343583
What this trial is testing

Effects of Sacral and Tibial Stimulation on Bladder Function in Subacute Suprasacral Spinal Cord Injury

Who this might be right for
Spinal Cord InjuryDetrusor Overacitivity
Ankara City Hospital Bilkent 45
Testing effectiveness (Phase 2)Study completedNCT05783219
What this trial is testing

Lidocaine Patches Prior to Percutaneous Nerve Evaluation

Who this might be right for
Overactive BladderUrge IncontinenceFecal Incontinence
University of Louisville 39
Early research (Phase 1)Ended earlyNCT03621982
What this trial is testing

Study of ADCT-301 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Head and Neck Cancer Squamous Cell CarcinomaNon-small Cell Lung CancerGastric Cancer+9 more
ADC Therapeutics S.A. 78
Testing effectiveness (Phase 2)UnknownNCT02886897
What this trial is testing

Combinations of D-CIK Immunotherapy And Anti-PD-1 In Refractory Solid Tumors

Who this might be right for
Hepatocellular CarcinomaRenal Cell CarcinomaBladder Cancer+3 more
Sun Yat-sen University 50
Not applicableLooking for participantsNCT00001823
What this trial is testing

Evaluation for NCI Surgery Branch Clinical Research Protocols

Who this might be right for
Synovial Cell CancerMelanomaColorectal Cancer+2 more
National Cancer Institute (NCI) 7,000
Not applicableLooking for participantsNCT07511244
What this trial is testing

SCS Therapy for Patients With Bladder and Bowel Dysfunction After SCI

Who this might be right for
Bladder and Bowel DysfunctionSCI - Spinal Cord Injury
Beijing Tsinghua Chang Gung Hospital 10
Early research (Phase 1)UnknownNCT05235607
What this trial is testing

Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Who this might be right for
CarcinomaMelanomaBladder Cancer+1 more
Sichuan University 60
Testing effectiveness (Phase 2)Study completedNCT03844412
What this trial is testing

Vestibulodynia: Understanding Pathophysiology and Determining Appropriate Treatments

Who this might be right for
VestibulodyniaTemporomandibular DisorderFibromyalgia Syndrome+7 more
Duke University 209
Not applicableLooking for participantsNCT06101277
What this trial is testing

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Who this might be right for
Small Bowel CancerColorectal CancerAppendiceal Cancer+5 more
University of California, Davis 300
Large-scale testing (Phase 3)Ended earlyNCT00332280
What this trial is testing

Study to Evaluate the Clinical Benefit Response in Cancer Patients With Advanced Disease With AMT2003 Versus Placebo

Who this might be right for
Gastrointestinal CancerProstate CancerGenital Neoplasms, Female
Auron Healthcare GmbH 67
Testing effectiveness (Phase 2)Study completedNCT05259696
What this trial is testing

Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01)

Who this might be right for
OncologyMelanomaOvarian Cancer+14 more
Palleon Pharmaceuticals, Inc. 69
Not applicableUnknownNCT04490642
What this trial is testing

Linguistic Validation of the Childhood Bladder and Bowel Dysfunction Questionnaire (CBBDQ) for 5-12 Years Old in Korean

Who this might be right for
Dysfunctional VoidingBladder DysfunctionBowel Dysfunction+1 more
Seoul National University Hospital 50
Early research (Phase 1)Ended earlyNCT02952989
What this trial is testing

A Safety Study of SGN-2FF for Patients With Advanced Solid Tumors

Who this might be right for
Carcinoma, Non-Small-Cell LungCarcinoma, Renal CellBreast Neoplasms+5 more
Seagen Inc. 47
Testing effectiveness (Phase 2)Study completedNCT03989115
What this trial is testing

Dose-Esc/Exp RMC4630 & Cobi in Relapsed/Refractory Solid Tumors & RMC4630& Osi in EGFR+ Locally Adv/Meta NSCLC

Who this might be right for
Solid Tumor
Revolution Medicines, Inc. 113
Next Page